240 related articles for article (PubMed ID: 31487266)
1. Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.
Durgin BG; Hahn SA; Schmidt HM; Miller MP; Hafeez N; Mathar I; Freitag D; Sandner P; Straub AC
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31487266
[TBL] [Abstract][Full Text] [Related]
2. Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.
Durgin BG; Wood KC; Hahn SA; McMahon B; Baust JJ; Straub AC
J Mol Cell Cardiol; 2022 Jan; 162():72-80. PubMed ID: 34536439
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.
Rahaman MM; Nguyen AT; Miller MP; Hahn SA; Sparacino-Watkins C; Jobbagy S; Carew NT; Cantu-Medellin N; Wood KC; Baty CJ; Schopfer FJ; Kelley EE; Gladwin MT; Martin E; Straub AC
Circ Res; 2017 Jul; 121(2):137-148. PubMed ID: 28584062
[TBL] [Abstract][Full Text] [Related]
4. Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice.
Wood KC; Durgin BG; Schmidt HM; Hahn SA; Baust JJ; Bachman T; Vitturi DA; Ghosh S; Ofori-Acquah SF; Mora AL; Gladwin MT; Straub AC
Blood Adv; 2019 Dec; 3(23):4104-4116. PubMed ID: 31821458
[TBL] [Abstract][Full Text] [Related]
5. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.
Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A
Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567
[TBL] [Abstract][Full Text] [Related]
6. Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.
Patel D; Alhawaj R; Kelly MR; Accarino JJ; Lakhkar A; Gupte SA; Sun D; Wolin MS
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1439-47. PubMed ID: 27037373
[TBL] [Abstract][Full Text] [Related]
7. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
[TBL] [Abstract][Full Text] [Related]
8. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
Jones AW; Durante W; Korthuis RJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
[TBL] [Abstract][Full Text] [Related]
9. Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.
Agbor LN; Nair AR; Wu J; Lu KT; Davis DR; Keen HL; Quelle FW; McCormick JA; Singer JD; Sigmund CD
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184598
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
11. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
[TBL] [Abstract][Full Text] [Related]
12. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
[TBL] [Abstract][Full Text] [Related]
13. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
[TBL] [Abstract][Full Text] [Related]
14. NO-induced vasodilation correlates directly with BP in smooth muscle-Na/Ca exchanger-1-engineered mice: elevated BP does not attenuate endothelial function.
Wang Y; Zhang J; Wier WG; Chen L; Blaustein MP
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H221-H237. PubMed ID: 33124883
[TBL] [Abstract][Full Text] [Related]
15. Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells.
Guo Y; Xu C; Man AWC; Bai B; Luo C; Huang Y; Xu A; Vanhoutte PM; Wang Y
Cardiovasc Res; 2019 Mar; 115(3):678-690. PubMed ID: 30165439
[TBL] [Abstract][Full Text] [Related]
16. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice.
Thoonen R; Cauwels A; Decaluwe K; Geschka S; Tainsh RE; Delanghe J; Hochepied T; De Cauwer L; Rogge E; Voet S; Sips P; Karas RH; Bloch KD; Vuylsteke M; Stasch JP; Van de Voorde J; Buys ES; Brouckaert P
Nat Commun; 2015 Oct; 6():8482. PubMed ID: 26442659
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the soluble guanylate cyclase heme redox state in blood vessels.
Tawa M; Okamura T
Vascul Pharmacol; 2022 Aug; 145():107023. PubMed ID: 35718342
[TBL] [Abstract][Full Text] [Related]
20. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
